Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 29, 2025 10:53 ET | Source: Block & Leviton LLP

BREAKING: MoonLake Immunotherapeutics Shares Down Over 85%; Investors Should Contact Block & Leviton to Potentially Recover Losses

Shares of MoonLake Immunotherapeutics are down over 85% today. Block & Leviton is investigating MoonLake's public statements about its drug trials.